Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04692571 · ClinicalTrials.gov registry record · Early Phase 1
EMG-Based Hand-Wrist Control: Study B Mirrored
A Early Phase 1 study, sponsored by Liberating Technologies.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 20
- Enrollment target
NCT04692571: Completed Early Phase 1 study, sponsored by Liberating Technologies.
NCT04692571 is a Early Phase 1 study that has completed, run by Liberating Technologies. The registered enrollment target is 20 participants, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (62% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04692571, a Early Phase 1 study, has completed, sponsored by Liberating Technologies.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 20 participants
- Enrollment target
Study Summary
Study assessing four-channel prosthesis controller, that compares contralateral (mirrored) EMG-force training to ipsilateral EMG-target training with both limb-absent and able-bodied subjects
Primary Outcome
Electromyogram waveform measurements (signal amplitude, frequency) will be related to force measurements (magnitude and moment) as related to the target tracking tasks. These signal-force data will be use to generate the models. The specific outcome for each subject will be the RMS error measured in the tracking tasks as the difference between the generated control signal from the user versus the prompted target signal, as measured by an EMG array.
Interventions
- DEVICE PSICON Measurement Apparatus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2017-06-29 |
| Est. Completion | 2020-08-24 |
| Phase | Early Phase 1 |
What the finished NCT04692571 record still lists
NCT04692571 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (62% lower).
The record links to 0 conditions, and to 1 intervention - of which PSICON Measurement Apparatus is the first listed.
NCT04692571 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04692571 about?
NCT04692571 is a clinical study titled "EMG-Based Hand-Wrist Control: Study B Mirrored". Study assessing four-channel prosthesis controller, that compares contralateral (mirrored) EMG-force training to ipsilateral EMG-target training with both limb-absent and able-bodied subjects
What is the current status of trial NCT04692571?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 20 participants. The study started on 2017-06-29. Estimated completion is 2020-08-24.
What interventions are being tested in trial NCT04692571?
The interventions under investigation include: PSICON Measurement Apparatus (DEVICE).
Who is sponsoring clinical trial NCT04692571?
This trial is sponsored by Liberating Technologies, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04692571's enrollment target sits among peer trials
20 1157th of 2000 higher than 709 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI